AURORA CANNABIS INC. and GLAS TRUST COMPANY LLC as Trustee INDENTURE Dated as of January 24, 2019 5.50% Convertible Senior Notes due 2024Indenture • January 28th, 2019 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • New York
INDENTURE dated as of January 24, 2019 between AURORA CANNABIS INC., a corporation organized and existing under the Business Corporations Act (British Columbia), as issuer (the “Company,” as more fully set forth in Section 1.01), and GLAS TRUST COMPANY LLC, a limited liability company organized and existing under the laws of the state of New Hampshire, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 11,500,000 Warrants November 16, 2020Aurora Cannabis Inc • November 28th, 2022 • Medicinal chemicals & botanical products • British Columbia
COMPUTERSHARE TRUST COMPANY OF CANADA a trust company continued under the laws of Canada and registered to carry on business in the Province of British Columbia
INDENTURE (Made as of November 28, 2017 Between AURORA CANNABIS INC. (the “Corporation”) and COMPUTERSHARE TRUST COMPANY OF CANADA (the “Trustee”)Indenture • October 5th, 2018 • Aurora Cannabis Inc • Ontario
CanniMed Therapeutics Inc.Aurora Cannabis Inc • February 9th, 2018 • Aurora
AURORA CANNABIS INC. as Borrower - and - THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Lenders - and - BANK OF MONTREAL as Administrative Agent - and - BANK OF MONTREAL as Lead Arranger and Sole Bookrunner SECOND AMENDED AND RESTATED CREDIT...Credit Agreement • January 22nd, 2021 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
SHAREHOLDER RIGHTS PLAN AGREEMENT BETWEEN AURORA CANNABIS INC. AND COMPUTERSHARE TRUST COMPANY OF CANADA Made as of November 30, 2018Shareholder Rights Plan Agreement • December 26th, 2018 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • British Columbia
AURORA CANNABIS INC. COMMON SHARES SALES AGREEMENTSales Agreement • May 20th, 2021 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • New York
Aurora Cannabis Inc. (the “Company”), confirms its agreement (this “Agreement”) with Citigroup Global Markets Inc. (“Citi”), Cowen and Company, LLC (“Cowen” and, together with Citi, the “Executing Agents”), ATB Capital Markets USA Inc. (“ATB”), BMO Capital Markets Corp. (“BMOCM”) and Canaccord Genuity LLC (“Canaccord” and, together with ATB and BMO, the “Additional Agents”, and the Additional Agents together with the Executing Agents, the “Agents”), as follows:
AURORA CANNABIS INC. and ANANDIA LABORATORIES INC. ARRANGEMENT AGREEMENT Dated as of July 15, 2018Arrangement Agreement • February 25th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • British Columbia
NOW THEREFORE in consideration of the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each of the Parties, the Parties hereto hereby covenant and agree as follows:
12,000,000 Units Aurora Cannabis Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • January 26th, 2021 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
Aurora Cannabis Inc., a corporation incorporated under the laws of British Columbia (the “Corporation”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 12,000,000 units (the “Firm Units”). Each Firm Unit shall consist of one common share of the Corporation (each a “Firm Share” and, collectively, the “Firm Shares”) and one-half of one common share purchase warrant of the Corporation (each whole common share purchase warrant, a “Firm Warrant” and, collectively, the “Firm Warrants”). The Firm Warrants and the Additional Warrants (as defined below), as applicable, shall be created and issued pursuant to a warrant indenture (the “Warrant Indenture”) to be dated as of the Closing Date (as defined in Section 5 hereof) between the Corporation and Computershare Trust Company of Canada, in its capacity as warrant agent thereunder (the “Warrant Agent”), and each Firm Warrant and Additional Warrant will entitle the holder thereof to acq
FIRST AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • February 25th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
SUPPORT AGREEMENTAgreement • January 30th, 2018 • Aurora Cannabis Inc • Ontario
and CANNIMED THERAPEUTICS INC. SUPPORT AGREEMENT January 24, 2018Support Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
THIS FIRST SUPPLEMENTAL INDENTURE is entered into as of the 25th day of July, 2018.First Supplemental Indenture • October 5th, 2018 • Aurora Cannabis Inc • Ontario
CanniMed Therapeutics Inc.Aurora Cannabis Inc • February 9th, 2018 • Aurora
Companies Also Sign Investor Rights AgreementServices Agreement • October 5th, 2018 • Aurora Cannabis Inc
VANCOUVER, Nov. 6, 2017 /CNW/ - Further to the two companies' joint press release of October 23, 2017, Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM)) and Radient Technologies Inc. ("Radient") (TSXV: RTI) today announced the companies have finalized a Master Services Agreement (the "Agreement"), pursuant to which Radient has agreed to perform certain services for Aurora using its proprietary MAP™ technology, as well as other technologies, as an independent contractor in relation to the development, commercialization and supply of standardized cannabis extracts. The Agreement has an initial term of five years, with an option for Aurora to renew the agreement for an additional five years.
FIRST AMENDMENT TO FIRST AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • April 17th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
WHEREAS the undersigned are parties to the first amended and restated credit agreement dated September 4, 2019 (the "Credit Agreement");
SUBSCRIPTION AGREEMENTSubscription Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
10094595 Canada Inc., a corporation incorporated under the laws of British Columbia, with its registered office at 1500 - 1199 West Hastings St., Vancouver, British Columbia V6E 3T5;
CanniMed Therapeutics Inc.Aurora Cannabis Inc • February 9th, 2018 • Aurora
THIRD AMENDMENT AND CONSENT TO FIRST AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • September 11th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
WHEREAS the undersigned are parties to the first amended and restated credit agreement dated September 4, 2019, as amended by a first amendment dated March 25, 2020 and a second amendment dated May 28, 2020 (as amended, the "Credit Agreement");
INVESTMENT AGREEMENTInvestment Agreement • September 20th, 2019 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Alberta
AURORA CANNABIS INC. – and – AURORA CANNABIS ENTERPRISES INC. – and – AURORA MARIJUANA INC. – and – CANVASRX INC. – and – EACH OF THE SHAREHOLDERS OF CANVASRX HOLDINGS INC.Share Purchase • October 5th, 2018 • Aurora Cannabis Inc • Alberta
ARRANGEMENT AGREEMENTArrangement Agreement • October 5th, 2018 • Aurora Cannabis Inc • British Columbia
with such exceptions, in the case of each of clauses (c)(ii) through (c)(iv), as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect with respect to the ICC Group.
SPECIAL WARRANT INDENTURE Providing for the Issue of Special WarrantsSpecial Warrant Indenture • October 5th, 2018 • Aurora Cannabis Inc
WHEREAS, pursuant to the terms of the Agency Agreement, the Corporation sold an aggregate of 115,000 Special Warrants at the purchase price of $1,000 per Special Warrant;
AURORA CANNABIS INC. COMMON SHARES SALES AGREEMENT AMENDMENTSales Agreement • April 17th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • New York
Reference is made to the sales agreement (the “Original Agreement”) among Aurora Cannabis Inc. (the “Company”), Cowen and Company, LLC (“Cowen”) and BMO Capital Markets Corp. (“BMOCM” and, together with Cowen, the “Executing Agents”), dated as of May 14, 2019. Capitalized terms used herein but not defined herein shall have the meaning given to those terms in the Original Agreement. Each of the Company, the Executing Agents and the Additional Agents (as defined below) hereby agrees as follows:
VOTING AND SUPPORT AGREEMENTVoting and Support Agreement • October 5th, 2018 • Aurora Cannabis Inc • British Columbia
Aurora Cannabis Inc. (“Aurora”) is concurrently herewith entering into an arrangement agreement (the “Arrangement Agreement”) with ICC Labs Inc. (“ICC”) which provides for, among other things, the acquisition by Aurora of all of the issued and outstanding common shares (the “Shares”) of ICC by way of a plan of arrangement (the “Plan of Arrangement”) under Section 288 of the Business Corporations Act (British Columbia) (the “BCBCA”) (the “Transaction”). Under the terms of the Arrangement Agreement, Aurora will acquire all of the issued and outstanding Shares at a price per Share of $1.95 payable in such number of common shares in the capital of Aurora (“Aurora Shares”) as is equal to the quotient of $1.95 divided by the volume-weighted average trading price of the Aurora Shares on the Toronto Stock Exchange in the twenty (20) Business Days (as such term is defined in the Arrangement Agreement) preceding the effective date of the Transaction (the last day of such period being the second
SUBSCRIPTION AGREEMENT FOR SUBSCRIPTION RECEIPTSSubscription Agreement • October 5th, 2018 • Aurora Cannabis Inc
The Subscriber acknowledges that the Issuer is not a “reporting issuer” (or equivalent thereof) in any jurisdiction, that the Subscription Receipts, Common Shares, Warrants and Warrant Shares are subject to an indefinite restriction on resale (i.e., a “hold period”) under applicable securities laws and that it will not be able to resell any of the Subscription Receipts, Common Shares, Warrants and Warrant Shares until expiration of the applicable hold period (which hold period will not commence to run until the Issuer has become a “reporting issuer” in a jurisdiction of Canada (which the Issuer has no obligation to become)) other than in accordance with limited exemptions under applicable securities legislation and regulatory policy.
Aurora and Namaste to Complete Strategic Private-Label Software and Patient Referral Agreements TSX: ACB CSE: NAurora Cannabis Inc • October 5th, 2018
EDMONTON and VANCOUVER, Jan. 2, 2018 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Namaste Technologies Inc. ("Namaste") (CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) today announced the signing of a binding term sheet towards a final Private-Label Software Agreement ("Private Label Agreement"), whereby Namaste will provide Aurora's wholly-owned subsidiary, CanvasRx Inc. ("CanvasRx") with a customized version of Namaste's patient acquisition tool, NamasteMD.com ("NamasteMD"), as well as desktop and mobile applications for Google Android and Apple iOS platforms. The companies have 30 days to complete a final agreement.
DEPOSITARY AGREEMENTDepositary Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
Aurora Cannabis Inc. (“Aurora”) and MedReleaf Corp. (“MedReleaf”, and together with MedReleaf, the “Companies”) wish to engage Computershare Investor Services Inc. (“Computershare”) as depositary in connection with a proposed plan of arrangement (the “Arrangement”) involving the Companies under an agreement dated May 14, 2018, as amended by an amending agreement dated May 24, 2018 (the “Arrangement Agreement”).
AURORA CANNABIS INC. - and - COMPUTERSHARE TRUST COMPANY OF CANADA WARRANT INDENTURE Providing for the Issue of up to 70,408,750 Warrants June 1, 2022Aurora Cannabis Inc • June 1st, 2022 • Medicinal chemicals & botanical products • British Columbia
a trust company continued under the laws of Canada and registered to carry on business in the Province of British Columbia
FIRST AMENDED AND RESTATED CREDIT AGREEMENTAnd • June 12th, 2020 • Aurora Cannabis Inc • Medicinal chemicals & botanical products • Ontario
For good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
MASTER SERVICES AGREEMENTInvestor Rights Agreement • October 5th, 2018 • Aurora Cannabis Inc • Alberta
Radient shall store the Input Material and Processed Material in a prescribed manner and in compliance with the terms of the ACMPR and the Quality Agreement.
INVESTOR RIGHTS AGREEMENT AURORA CANNABIS INC. and THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD. and ROBERT ANDERSON January 12, 2018 ___________________________Investor Rights Agreement • October 5th, 2018 • Aurora Cannabis Inc • Ontario
WHEREAS the Company and the Investor have entered into a subscription agreement dated January 4, 2018 (the “Subscription Agreement”) whereby the Investor purchased subscription receipts to acquire common shares and warrants of the Company, which when issued would represent approximately 15% of the Company’s issued and outstanding common shares on a fully diluted basis (based on the Company’s outstanding common shares at the issue date);
